Advertisement

Risk factors for post-stroke depression in Sohag University Hospital

  • Gharib Fawi Mohammed
  • Hemaid Mostafa Azab
  • Mohamed Abd-Elmoneim Sayed
  • Hassan Mohammed ElnadyEmail author
  • Hanan Youssif
  • Ossama Abd-Alreheem Mahmoud
Open Access
Research
  • 56 Downloads

Abstract

Background

Depression is one of the important complications of stroke. Post-stroke depression is associated with more physical disability, especially in daily activities, poor functional outcome, and high mortality rate.

Objective

Our study aimed to investigate the risk factors for development of post-stroke depression 3 months following stroke.

Methods

This is a comparative study, comparing stroke patients with and without depression 3 months after the onset. Hamilton Depression Rating Scale (HDRS), Mini-Mental State Examination (MMSE), Scandinavian Stroke Scale (SSS), and modified Rankin scale (mRS) were used to evaluate patients 3 months post-stroke for depression, cognition, and physical disability. The patients were divided into two groups: patients’ group with depression and patients’ group without depression according to DSM-IV criteria. The clinical characteristics and scores on the HDRS, MMSE, SSS, and mRS were compared between depressive group and non-depressive group. Logistic regression analysis was performed to identify risk factors for depression 3 months after stroke.

Results

A total 102 stroke patients were recruited. Of these, 62 patients (60.78%) had depression. Multivariate logistic regression indicated that smoking, hypertension, increased physical disability, and impaired cognitive function were associated with post-stroke depression.

Conclusion

Important risk factors found for PSD included smoking, hypertension, increased physical disability, and impaired cognitive function.

Keywords

Stroke Depression Risk factors 

Abbreviations

GCS

Glasgow Coma Scale

HDRS

Hamilton Depression Rating Scale

MMSE

Mini-Mental State Examination

mRS

Modified Rankin scale

PSD

Post-stroke depression

SSRI

Selective serotonin reuptake inhibitors

SSS

Scandinavian Stroke Scale

Introduction

Stroke is related to high morbidity and mortality rate throughout the world. Its sudden onset and its remaining mental or physical sequelae have a negative effect on whatever is left of life [1].

Depression is one of the critical complications of stroke [2]. Its prevalence was evaluated to be from 20 to 65%, contingent upon the population studied, the assessment tools, and the defining criteria of depression [3]. Post-stroke depression (PSD) is associated with more physical disability, particularly in day by day activities, poor functional outcome, and high death rate [4].

Previous history of depression, the severity of neurological deficit, functional dependency, and pre-stroke depression have been reported as predictive factors of PSD in developed countries. Some authors also report the relationship between post-stroke depression and sociodemographic characteristics (gender, age), but the results are still controversial [5].

Our study aimed to investigate the risk factors for development of post-stroke depression 3 months following stroke for early detection, rapid management, to improve patients’ and care givers’ quality of life.

Material and methods

This is a comparative study, comparing first ever stroke patients with and without depression 3 months after the onset. The cases came from a series of consecutive patients attending the Neurology Outpatient Clinic of Sohag University Hospital from February 2012 to March 2013. The total sample was divided into two groups, stroke patients presented with (group A) and without (group B) depression. Stroke was defined according to the definition of the World Health Organization as the rapid onset of a new persistent neurological deficit attributable to an obstruction in cerebral blood flow with no apparent non-vascular cause [6]. Patients with aphasia, mental illness (e.g., schizophrenia or dementia), substance-related disorders, chronic organic illness (e.g., renal or hepatic failure), or patients using SSRI were excluded. Consents were obtained from participants. The study was approved by the local Ethical Committee of Sohag Faculty of Medicine, Sohag University. Written consent was obtained from all participants.

The following data were collected (from patients’ files during admission): age, gender, smoking, hypertension, hypercholesterolemia, diabetes mellitus, history of cardiac disease, including rheumatic heart disease, atrial fibrillation, coronary artery disease, myocardial infarction, heart failure, and positive family history for cerebrovascular stroke. Patients were categorized as hypertensive if their blood pressure readings preceding the index stroke had repeatedly surpassed 140/95 mmHg, or if they were taking medication to control hypertension, the subjects were considered to be diabetics if they used oral hypoglycemic agents or insulin, and as having heart disease when known before admission or diagnosed on admission. Clinical data on admission were collected, including systolic and diastolic blood pressure, admission temperature, pulse rate and its rhythm, the presence of hiccough or vomiting, side of weakness, the presence of aphasia, among non-comatose patients, severity of stroke using the Glasgow Coma Scale (GCS), and Scandinavian Stroke Scale [7]. The following laboratory data were evaluated: blood sugar, serum creatinine, complete blood count, coagulation profile, erythrocyte sedimentation rate, serum electrolytes, and liver function tests. Radiological data, on admission, were also evaluated to determine the type and site of cerebrovascular stroke.

All cases assessed using

Hamilton Depression Rating Scale (Arabic version) [8] was performed by a skillful neuropsychologist who carried out the interview to diagnose depression within 3 months after stroke onset according to DSM-IV criteria. The severity of depression was evaluated utilizing the 17-item Hamilton Rating Scale for Depression (HAMD-17) within 3 months after stroke onset [9]. To be incorporated into the major depression group in our final analysis, subjects needed to meet DSM-IV criteria for major depressive disorder. The other participants were allotted to either the control group.

Mini-Mental State Examination [10] is a broadly utilized cognitive screening test, where scores from 24 to 30 are considered within the normal range. Items address orientation, memory, recall, attention, naming objects, following verbal and written commands, writing a sentence, and copying a figure.

The outcome was assessed at 3 months after the stroke by clinical examination utilizing the modified Rankin scale (mRS). The mRS scale scores of 0 to 1 were categorized as “favorable” and mRS scores of 2 to 6 as “unfavorable” outcome [11, 12, 13].

Statistical methods

Data was analyzed using STATA intercooled version 9.2. Categorical variables were expressed as frequency and percentage while continuous variables were expressed as mean ± standard deviation. Quantitative data were analyzed using the Mann-Whitney U test to compare two groups as the data was not normally distributed. Qualitative data were compared using either chi-square test or Fisher exact test. Simple logistic regression analysis was used to identify factors predicting depression. A logistic regression analysis, which included variables that showed statistical differences on univariate comparison, was performed.

Results

During the study period, 102 patients were eligible for analysis (43 males and 59 females) with age ranging from 18 to 87 years presented 3 months post-stroke. Sixty-two patients were categorized as group A and 40 patients as group B. There was no statistically significant difference between patients with and without depression as regard to age, sex, and type of stroke as shown in (Table 1).
Table 1

Demographic data and type of stroke in both groups

 

Group A

Patients with depression

Group B

Patients without depression

p value

Number

Percentage

Number

Percentage

62

60.78%

40

39.22%

Age (mean (SD)

56.67 (10.43)

 

56.7 (13.03)

 

0.30

Sex

 Females

35

59.32%

24

40.06%

0.69

 Males

27

62.79%

16

37.20%

 

Type of stroke

 Hemorrhage

n = 13

68.42%

n = 6

31.57%

0.40

 Infarction

n = 49

59.30%

n = 34

40.96%

 
Smoking was more prevalent in group A than in group B (p = 0.03). Patients with depression were more often hypertensive (p value < 0.003) and diabetic (p value < 0.01). There was no statistically significant difference between two groups as regards the prevalence of cardiac disease (p value 0.10), laboratory findings, and side or site of lesion as shown in (Table 2).
Table 2

Clinical, laboratory, and radiological data in both groups

 

Group A

Patients with depression

Group B

Patients without depression

p value

Total n = 62

Percentage (%)

Total n = 40

Percentage (%)

Smoking

37

75.75

8

24.24

< 0.03

Hypertension

32

78.04

9

21.95

< 0.003

Diabetes mellitus

36

78.78

7

21.21

< 0.01

Cardiac disease

9

47.36

10

52.63

0.10

Hypercholesterolemia

19

59.37

13

40.62

0.12

Hypertriglyceridemia

14

60.87

9

39.13

0.15

Low HDLC

41

60.29

27

39.70

0.15

High LDLC

12

60.00

8

40.00

0.15

Side of the lesion

    

0.45

Free CT brain on admission

n = 8

53.33

n = 7

46.66

 

Left cerebral hemisphere

n = 12

40.00

n = 18

60.00

 

Right cerebral hemisphere

n = 20

35.08

n = 37

64.91

 

Site of lesion

Free CT brain on admission

8

53.33

7

46.66

0.52

Basal ganglionic

8

34.74

15

65.21

 

Cerebellar

2

50.00

2

50.00

 

Thalamic

1

25.00

3

75.00

 

Frontal

7

38.88

11

61.11

 

Occipital

1

33.33

2

66.66

 

Parietal

13

46.42

15

53.57

 

Temporal

3

42.85

4

57.14

 
Patients in group A were more likely to have impaired cognitive function than those in group B, and the difference was statistically significant (p value < 0.0001). A higher stroke severity, measured by Scandinavian Stroke Scale, was significantly higher in patients with depression (p value < 0.005). The prevalence of unfavorable clinical outcome assessed with the mRS was significantly higher in group A (p value < 0.0001) (Table 3).
Table 3

Different applied scales in both groups

 

Group A

Patients with depression

total n = 62

Group B

Patients without depression total n = 40

p value

MMS: mean (SD)

26.93 (2.74)

24.89 (2.09)

< 0.0001

SSS score: mean (SD)

39.8(13.71)

30.63 (11.09)

0.005

mRS: mean (SD)

2.05 (1.22)

3.00 (0.75)

< 0.0001

Table 4 shows the multivariate analysis using logistic regression model and odds ratios for each of the factors. The model indicated that smoking (p value < 0.03), hypertension (p value < 0.01), increased physical disability (unfavorable outcome) according to mRS (p value < 0.01), higher stroke severity (p value 0.01), and impaired cognitive function (p value < 0.01) were associated with post-stroke depression.
Table 4

Logistic regression model of significant risk factors associated with post-stroke depression

 

Multivariate analysis

0dds ratio (95% CI)

p value

Smoking

3.56 (1.10–11.52)

0.03

Hypertension

4.76 (1.42–15.92)

0.01

Modified Rankin scale score

3.72 (1.30–10.69)

0.01

Scandinavian Stroke Scale score

4.84 (1.40–16.70)

0.01

Mini-Mental State of Examination

3.75 (1.18–11.90)

0.01

Discussion

The interaction between stroke and depression is exceptionally intricate, and the pathophysiological mechanisms have not as yet been fully explained [14].

Various studies explored prevalence and risk factors for PSD, but inconstant results were reported relying on the studied subjects, assessment tools, and the diagnostic criteria of depression used [15].

The prevalence of PSD in our study was 60.78%, which was higher than previously reported studies [16, 17, 18], and in line with other studies, which reported that the prevalence of PSD ranged from 5 to 63% [19] and from 25 to 79% [20]. Differences in reported prevalences of previous studies are likely a result of differences in methods of measurement and a function of the timing of the evaluation [13].

Because of the unfavorable impacts of PSD, it is essential to distinguish risk factors to allow for an early diagnosis and management, in this way diminishing the negative impacts in stroke patients [21].

In the current study, there was no relationship between the demographic data (age and sex) and PSD. The results for the relationship between PSD and demographic data are controversial [22]. Some of the earlier reports are in agreement with our results [5, 23], while others are not [21, 24].

Contrary to our results, it was reported that patients under 50 years old occupy a higher percentage of subjects with depression [23]. Also, it was recognized that younger patients appear to be more attentive about the prognosis of the disease [4, 25].

In an Egyptian study, the authors found that male gender, younger age, and frontal lesions were predictors for post-stroke depression [26].

In another Egyptian study, to detect the depression, anxiety, and personality traits in post-stroke patient, there was no significant relation between demographic data and depression in post-stroke patients [27].

Although smoking and hypertension were established risk factors for development of stroke [28], they were not reported as risk factors for development of PSD [13, 29].

Among our subjects, smoking was related to PSD in univariate and multivariate analysis. This is in accord with a study by Ren and colleagues who reported that the frequency of depression in the smoker group was significantly higher than that in the non-smoker group [30]. In addition, Ren and colleagues reported that, the larger proportion of patients with depression in smokers with acute ischemic stroke may be related to lower vitamin D levels induced by smoking [30].

In our study, patients with post-stroke depression had a significant functional disability in (cognition, physical activity) compared to stroke patients without depression, which was consistent with many previous studies that had reported a significant relationship between disability and post-stroke depression [15, 31, 32, 33, 34].

De Ryck and colleagues [13] conducted a prospective, longitudinal epidemiological study in 135 patients who completed follow-up assessments at 3 months post-stroke; they concluded that the most determining features for depression risk after stroke included reduced mobility and cognitive impairment. Leentjens and colleagues [35] assessed 190 consecutively admitted patients for major depressive disorder 1 month after stroke, and at follow-up after 3, 6, 9, and 12 months, they revealed that disability was associated with PSD. Nys and colleagues [36] studied 143 cases within the first 3 weeks post-stroke; they revealed that cognitive impairment and vascular risk factors were significant predictors of long-term depressive symptoms and quality of life after stroke.

Our study had several limitations. The sample size was small which generates imprecision in some estimates. The study population included both ischemic and hemorrhagic strokes. We did not differentiate types of strokes according to TOAST criteria. In addition, we excluded patients with aphasia because this might limit the generalization of our findings. Moreover, the socioeconomic factors and education were not included in the analysis.

Conclusion

Depression was found to be an important complication among stroke survivors in our study. Important risk factors found for PSD included smoking, hypertension, increased physical disability, and impaired cognitive function. Early diagnosis and adequate therapy are still necessary in stroke rehabilitation to attenuate stroke complication.

Notes

Acknowledgements

Not applicable.

Funding

None.

Availability of data and materials

The data set of this work is available and uploaded with this article.

Authors’ contributions

GF participated in the design of the study and supervised the findings of this work. HA conceived of the study and participated in its design and coordination. MS analyzed the data and was involved in the study design. HE and HY wrote the paper, drafted the manuscript, and designed the tables. OA was involved in the data acquisition and analysis. All authors discussed the results and commented on the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The study was approved by the local Ethical Committee of Sohag Faculty of Medicine, Sohag University on December 13, 2011, Informed written (when available) consent was obtained from all patients for participation and publication of this study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.
    Li CT, et al. Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study. PLoS One. 2012;7(10):e46818.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Hackett ML, Anderson CS. Predictors of depression after stroke: a systematic review of observational studies. Stroke. 2005;36(10):2296–301.PubMedGoogle Scholar
  3. 3.
    De Ryck A, et al. Risk factors for poststroke depression: identification of inconsistencies based on a systematic review. J Geriatr Psychiatry Neurol. 2014;27(3):147–58.PubMedGoogle Scholar
  4. 4.
    Karamchandani RR, et al. Early depression screening is feasible in hospitalized stroke patients. PLoS One. 2015;10(6):e0128246.PubMedPubMedCentralGoogle Scholar
  5. 5.
    dos Santos EB, Rodrigues RAP, Pontes-Neto OM. Prevalence and predictors of post stroke depression among elderly stroke survivors. Arq Neuropsiquiatr. 2016;74(8):621–5.PubMedGoogle Scholar
  6. 6.
    Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–53.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Gray LJ, et al. Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in acute stroke. J Stroke Cerebrovasc Dis. 2009;18(6):466–8.PubMedGoogle Scholar
  8. 8.
    Lotfy H. Hamilton Rating Scale of depression (HDRS). Cairo: Dar El-Anglo; 1994.Google Scholar
  9. 9.
    Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–96.PubMedGoogle Scholar
  10. 10.
    Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group. Stroke. 1985;16(5):885–90.Google Scholar
  11. 11.
    Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19(12):1497–500.PubMedGoogle Scholar
  12. 12.
    van Swieten JC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.PubMedGoogle Scholar
  13. 13.
    De Ryck A, et al. A prospective study on the prevalence and risk factors of poststroke depression. Cerebrovasc Dis Extra. 2013;3(1):1–13.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Zhang Y, et al. Neural complexity in patients with poststroke depression: a resting EEG study. J Affect Disord. 2015;188:310–8.PubMedGoogle Scholar
  15. 15.
    Oliveira CR, et al. Depressive signs and cognitive performance in patients with a right hemisphere stroke. Codas. 2015;27(5):452–7.PubMedGoogle Scholar
  16. 16.
    Kouwenhoven SE, et al. Depressive symptoms in acute stroke: a cross-sectional study of their association with sociodemographics and clinical factors. Neuropsychol Rehabil. 2013;23(5):658–77.PubMedGoogle Scholar
  17. 17.
    Snaphaan L, et al. Post-stroke depressive symptoms are associated with post-stroke characteristics. Cerebrovasc Dis. 2009;28(6):551–7.PubMedGoogle Scholar
  18. 18.
    Johnson JL, et al. Poststroke depression incidence and risk factors: an integrative literature review. J Neurosci Nurs. 2006;38(4 Suppl):316–27.PubMedGoogle Scholar
  19. 19.
    Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151–62.PubMedGoogle Scholar
  20. 20.
    Hosking SG, Marsh NV, Friedman PJ. Depression at 3 months poststroke in the elderly: predictors and indicators of prevalence. Aging Neuropsychol Cogn. 2000;7(4):205–16.Google Scholar
  21. 21.
    Tsai CS, et al. Incidence and risk factors of poststroke depression in patients with acute ischemic stroke: a 1-year prospective study in Taiwan. Biom J. 2016;39(3):195–200.Google Scholar
  22. 22.
    Kutlubaev MA, Hackett ML. Part II: predictors of depression after stroke and impact of depression on stroke outcome: an updated systematic review of observational studies. Int J Stroke. 2014;9(8):1026–36.PubMedGoogle Scholar
  23. 23.
    Jiao JT, et al. Association between inflammatory cytokines and the risk of post-stroke depression, and the effect of depression on outcomes of patients with ischemic stroke in a 2-year prospective study. Exp Ther Med. 2016;12(3):1591–8.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Tang WK, et al. Poststroke depression in Chinese patients: frequency, psychosocial, clinical, and radiological determinants. J Geriatr Psychiatry Neurol. 2005;18(1):45–51.PubMedGoogle Scholar
  25. 25.
    Carota A, et al. A prospective study of predictors of poststroke depression. Neurology. 2005;64(3):428–33.PubMedGoogle Scholar
  26. 26.
    Effat SM, Mohamed MM, El Essawy HI, El Sheikh MM, Abdul Aal HS. Predictors and Consequences of Post-Stroke Depression in a Sample of Egyptian. Arab J Psychiatry. 2011;22(1):19–26.Google Scholar
  27. 27.
    Shehata GA, Hassan HS. Personality traits, depression and anxiety among cerebro-vascular stroke patients: an Egyptian study. Int Neuropsychiatric Dis J. 2014;2(6):280–8.Google Scholar
  28. 28.
    Park TH, et al. Identifying target risk factors using population attributable risks of ischemic stroke by age and sex. J Stroke. 2015;17(3):302–11.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Yang SR, et al. Predictors of early post ischemic stroke apathy and depression: a cross-sectional study. BMC Psychiatry. 2013;13:164.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Ren W, et al. The effect of cigarette smoking on vitamin D level and depression in male patients with acute ischemic stroke. Compr Psychiatry. 2016;65:9–14.PubMedGoogle Scholar
  31. 31.
    Srivastava A, et al. Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol. 2010;13(2):123–7.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Paolucci S, et al. The Italian multicenter observational study on post-stroke depression (DESTRO). J Neurol. 2006;253(5):556–62.PubMedGoogle Scholar
  33. 33.
    Glodzik-Sobanska L, et al. Depressive symptoms following ischemic stroke. Neurol Neurochir Pol. 2003;37(1):17–25.PubMedGoogle Scholar
  34. 34.
    Parikh RM, et al. Two-year longitudinal study of post-stroke mood disorders: dynamic changes in correlates of depression at one and two years. Stroke. 1987;18(3):579–84.PubMedGoogle Scholar
  35. 35.
    Leentjens AF, et al. General and disease-specific risk factors for depression after ischemic stroke: a two-step Cox regression analysis. Int Psychogeriatr. 2006;18(4):739–48.PubMedGoogle Scholar
  36. 36.
    Nys GM, et al. Early cognitive impairment predicts long-term depressive symptoms and quality of life after stroke. J Neurol Sci. 2006;247(2):149–56.PubMedGoogle Scholar

Copyright information

© The Author(s) 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  • Gharib Fawi Mohammed
    • 1
  • Hemaid Mostafa Azab
    • 1
  • Mohamed Abd-Elmoneim Sayed
    • 1
  • Hassan Mohammed Elnady
    • 1
    Email author
  • Hanan Youssif
    • 1
  • Ossama Abd-Alreheem Mahmoud
    • 1
  1. 1.Department of Neurology and Psychological Medicine, Faculty of Medicine, Sohag UniversitySohagEgypt

Personalised recommendations